Cargando…
Dimethyl fumarate treatment for psoriasis in a real‐life setting: A multicentric retrospective study
Dimethyl fumarate (DMF) is a fumaric acid esters derivate approved for plaque psoriasis as first‐line systemic therapy. It has been available in Italy since 2017 and an increasing number of patients are treated with this drug. To evaluate DMF effectiveness, side effects and drug survival in a dermat...
Autores principales: | Corazza, Monica, Odorici, Giulia, Conti, Andrea, Di Lernia, Vito, Motolese, Alberico, Bardazzi, Federico, Di Nuzzo, Sergio, Monti, Alberto, Arginelli, Federica, Filippi, Federica, Valpiani, Giorgia, Morotti, Chiara, Borghi, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286462/ https://www.ncbi.nlm.nih.gov/pubmed/34291547 http://dx.doi.org/10.1111/dth.15066 |
Ejemplares similares
-
Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study
por: GNESOTTO, Laura, et al.
Publicado: (2023) -
Infliximab-induced intertriginous psoriasis in patient with Crohn's disease
por: Mola, Federica, et al.
Publicado: (2011) -
Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
por: Di Lernia, V, et al.
Publicado: (2016) -
Does longer duration of corticosteroid treatment improve clearance in vulvar lichen sclerosus? Results from a single centre, comparative, open label study
por: Corazza, Monica, et al.
Publicado: (2021) -
COVID-19 in multiple sclerosis patients treated with dimethyl fumarate
por: Capone, Fioravante, et al.
Publicado: (2021)